Some antidepressants get better as the dose goes higher, while others just fizzle. For older patients, the side effects stack up as the benefits plateau. We review 3 new meta-analyses on antidepressant dosing, and bring you 4 updates on how the coronavirus is changing practice regulation.Date Published: 3/30/2020Duration: 27 minutes,...

A new study finds that sugar makes people feel worse - not just in the long term but in the short term as well. We interview the lead investigator Dr. Konstantinos Mantantzis and ponder the mystery of how something that makes us feel so bad creates such intense cravings.Published on:...

How do you make the most of brief therapy during a medication visit? Chris Aiken, MD, pulls a few of his favorite interventions from his new book, The Depression and Bipolar Workbook.Date Published: 3/16/20Duration: 20 minutes 24 seconds...

Is oxcarbazepine really a kinder, gentler mood stabilizer? We dig through the published and unpublished trials and talk with Dr. Tammas Kelly, a psychiatrist who’s found a niche for the anticonvulsant.Published on: 3/9/2020Duration: 15 minutes, 9 seconds...

This is a special episode covering coronavirus for mental health care professionals with a focus on children and adolescents. Dr. Feder discusses basic information on symptoms, minimizing transmission, tips for telepsychiatry, talking about the virus with patients prone to anxiety, and addressing cultural bias.Date published: 3/6/2020 Duration: 15 minutes, 11 secondsLinks and...

Faking a smile drives service workers to drink. The down-side of social skills training. Dental health improves brain health, but straighter teeth do little for self-esteem. And an addictions program doubles their recovery rates with a little help from their dental friends, all in this research round-up on the mouth-brain...

Families bring difficult questions when their loved one has dementia, and in this interview with Cathy Howard, RN, we’ll show you how to answer some of them. We also delve into the nonpharmacologic approaches to agitation in dementia to learn what they look like in real life.Published On: 2/20/20Duration: 8 minutes, 9...

Nuedexta. A 60 year old cough medicine gets approve for uncontrollable crying, but the drug company has its eyes on a bigger target: Agitation in dementia. Follow the trail of pseudoscience, bribery, and indictments, and learn a few clinical pearls about this dextromethorphan-quinidine combination along the way.Published On: 2/17/20Duration: 15 minutes, 51...

30-50% of patients with depression have signs of inflammation, and some of those markers may help predict which medication they'll respond to. Andrew Miller, MD, of Emory University is one of the leading researchers in this field, and in this interview he tells us when to suspect inflammation and how...

A new antidepressant is under development that could change the field even more than esketamine. And even if it doesn't, its novel effects on the mind reveals something that can help our patients today. This fascinating drug was commonly prescribed by psychiatrists in the 1950's until Richard Nixon tried to...